Delivery Order SPE2DR25D6028-SPE2DR26FASPY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $31,919.22 to AmerisourceBergen Drug Corp for CIPROFLO-DEXA 7.5ML pharmaceutical product on December 8, 2025, with an ultimate completion date of January 6, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,775.74 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ciproflo-Dexa 7.5ML medication. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. The work is scheduled for completion by November 25, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,375.68 to AmerisourceBergen Drug Corp for the supply of CIPROFLO-DEXA 7.5ML on June 18, 2025, with completion targeted for July 17, 2025. This competitive award, which included no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,332.90 for CIPROFLO-DEXA 7.5ML on August 7, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, PA. The contract is funded through the Defense Logistics Agency's Medical...
- This is a $32,348.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the medical product "CIPROFLO-DEXA 7.5ML 1S" and has a completion date of July 24, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Ciproflo-Dexa 7.5ML. This competitively awarded, non-set-aside contract carries a firm fixed price ceiling value of $38,253.93 with an ultimate completion date of October 1, 2025. The delivery order represents a continuation of AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $13,961.35 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL on December 3, 2025, with an ultimate completion date of December 4, 2025. The contract employs firm fixed price pricing and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,569.12 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 6, 2025, with completion targeted for August 7, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a $2,410.72 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Ciprofloxacin 400 mg/200 ml in 5% Dextrose solution. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 11, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract does not utilize a set-aside designation and represents a child order under a larger contract...
- The Defense Logistics Agency awarded a $1,452.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone otic suspension (7.5 mL), with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999 and extending through December 2026. The prime IDC serves as a...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASPYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,981.78 to AmerisourceBergen Drug Corp for CIPROFLO-DEXA 7.5ML 1S on December 10, 2025, with an ultimate completion date of December 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this medical supply requirement as a child delivery order under a larger contract vehicle. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, medical devices, and specialized healthcare commodities. The contractor's extensive federal contract portfolio demonstrates consistent capability to meet competitive federal procurement requirements across multiple therapeutic domains and product categories for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 12/9/25 |